Ignite Creation Date:
2024-07-17 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06483698
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-03-12
Brief Title:
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
Sponsor:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Study Overview
Official Title:
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery A Retrospective Multi-center Study EarlyLC-RW
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EarlyLC-RW
Brief Summary:
The goal of this observational study is to evaluate the efficacy and long-term clinical outcomes of early-stage lung cancer patients who have received surgery using the real-world data The main questions it aims to answer are
What is the best surgical strategy for patients with early-stage lung cancer
What are the risk factors for early-stage lung cancer Participants will receive surgery and the study will analyze the real-world data
What is the best surgical strategy for patients with early-stage lung cancer
What are the risk factors for early-stage lung cancer Participants will receive surgery and the study will analyze the real-world data
Detailed Description:
This observational study aims to comprehensively evaluate the effectiveness and long-term clinical outcomes of surgical interventions in early-stage lung cancer patients utilizing real-world data
Central to this investigation are two key questions
What is the optimal surgical approach for managing early-stage lung cancer
What are the primary risk factors associated with the development of early-stage lung cancer Participants will undergo surgical procedures and through rigorous analysis of real-world data this study endeavors to provide nuanced insights into these fundamental queries fostering advancements in clinical decision-making and patient management strategies
Central to this investigation are two key questions
What is the optimal surgical approach for managing early-stage lung cancer
What are the primary risk factors associated with the development of early-stage lung cancer Participants will undergo surgical procedures and through rigorous analysis of real-world data this study endeavors to provide nuanced insights into these fundamental queries fostering advancements in clinical decision-making and patient management strategies
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None